Pharmaceuticals - Indian - Bulk Drugs
Peer Comparison
Company | LTP | Market Cap (in ₹ Cr) |
---|---|---|
Auro Laboratories Ltd | ₹253.85 | ₹158.15 |
Sun Pharmaceuticals Industries Ltd | ₹1,858.70 | ₹4,45,964.39 |
Divis Laboratories Ltd | ₹5,901 | ₹1,56,653.01 |
Cipla Ltd | ₹1,559.20 | ₹1,25,920.28 |
Torrent Pharmaceuticals Ltd | ₹3,207.70 | ₹1,08,558.27 |
Mankind Pharma Ltd | ₹2,690.55 | ₹1,07,795.31 |
01 Aug 2024
31 May 2024
18 May 2024
01 Feb 2024
06 Nov 2023
Financials
Profit and Loss
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | - | 53.84 | 51.96 | 55.01 | 44.76 |
Total Expenses | - | 50.39 | 48.08 | 44.50 | 39.12 |
Profit Before Tax | - | 3.45 | 3.87 | 10.51 | 5.64 |
Profit After Tax | - | 2.44 | 2.84 | 7.18 | 4.05 |
Operating Profit after Depreciation | - | 4.26 | 4.70 | 10.96 | 6.22 |
Balance Sheet
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | - | 12.62 | 13.61 | 13.56 | 14.24 |
Total Non Current Assets | - | 20.33 | 17.33 | 13.74 | 14.40 |
Total Current Assets | - | 35.66 | 37.63 | 28.15 | 17.95 |
TOTAL ASSETS | - | 55.99 | 54.96 | 41.89 | 32.35 |
Total Shareholder's Fund | - | 34.20 | 31.52 | 28.58 | 21.50 |
Cash Flow
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 18.81 | 3.28 | -6.59 | 12.82 | 9.30 |
Net Cash used in Investing Activities | -38.67 | -5.08 | -5.34 | -3.51 | -2.21 |
Net Cash used in Financing Activities | 19.09 | -8.18 | 9.79 | -0.46 | -5.52 |
Corporate Actions